コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ma-free days (i.e., fewer days without acute brain dysfunction).
2 he degenerative diseases of aging, including brain dysfunction.
3 rocytic consequences of cirrhosis-associated brain dysfunction.
4 lying synaptic and nonsynaptic mechanisms of brain dysfunction.
5 d reverses neurofibrillary tangle-associated brain dysfunction.
6 ay help prevent and modulate the severity of brain dysfunction.
7 urbs inhibitory synapse formation and causes brain dysfunction.
8 acement, debility, neurologic disorders, and brain dysfunction.
9 ed by H2O2, might contribute to H2O2-induced brain dysfunction.
10 l neurodegenerative diseases and age-related brain dysfunction.
11 whereas recessive mutations lead to skin and brain dysfunction.
12 n and cell death do not play a major role in brain dysfunction.
13 treatment are recommended to prevent ongoing brain dysfunction.
14 care unit survivors at high risk of ongoing brain dysfunction.
15 lth problem in the form of acute and chronic brain dysfunction.
16 arly iron treatment in preventing ID-induced brain dysfunction.
17 tient is not necessarily free of significant brain dysfunction.
18 zepine drugs and may lower the risk of acute brain dysfunction.
19 on of pain in migraine is due to lateralized brain dysfunction.
20 d of mechanisms by which infection can cause brain dysfunction.
21 lular and molecular mechanisms that underlie brain dysfunction.
22 s well as processes that lead to age-related brain dysfunction.
23 sses the blood-brain barrier (BBB) to induce brain dysfunction.
24 vels may contribute to neurodegeneration and brain dysfunction.
25 y present a sensitive measure of HIV-related brain dysfunction.
26 ily a neurological disorder with progressive brain dysfunction.
27 her factors in shaping the risk of postnatal brain dysfunctions.
28 consistent with the concept of developmental brain dysfunction, a term we use to describe the abnorma
29 rium is a highly prevalent syndrome of acute brain dysfunction among critically ill patients that has
31 asoprotective role of PGRN may contribute to brain dysfunction and damage in conditions associated wi
34 crete population of neurons can cause global brain dysfunction and that phenotype severity depends on
35 sorders was to establish the most consistent brain dysfunctions and to address task- and subtype-rela
36 tandard iron indicators to detect ID-induced brain dysfunction, and evaluate the efficacy of early ir
38 when disorders encompassed by developmental brain dysfunction are considered as a group, the penetra
40 zheimer transgenic mouse studies demonstrate brain dysfunction, as beta-amyloid levels rise, months b
41 ewborns have a prominently increased risk of brain dysfunctions attributed to white-matter damage, wh
42 vascular reactivity predicts prolonged acute brain dysfunction, but relationships between endothelial
43 e findings imply that regional variations in brain dysfunction can occur in Alzheimer's disease, with
44 information is useful for understanding how brain dysfunctions contribute to movement disorders such
45 phan ratios and presence or absence of acute brain dysfunction (defined as delirium/coma-free days) i
46 nine pathway activity in intensive care unit brain dysfunction (delirium and coma) remains unknown.
48 nuates the development of neuropathology and brain dysfunction during acute and chronic phases includ
52 ye movement disorders in patients with focal brain dysfunction have added to our understanding of hum
53 Additionally, possible mechanisms for gut-brain dysfunction have been identified, suggesting prima
54 benzodiazepine drugs may contribute to acute brain dysfunction, ie, delirium and coma, associated wit
55 heral inflammation as potential mediators of brain dysfunction in AD may lead to the development of e
56 yloid plaques and neurofibrillary tangles to brain dysfunction in Alzheimer disease is critical for t
60 To determine the metabolic substrates of brain dysfunction in DYT1 dystonia, we scanned 7 nonmani
61 stence of different mechanisms of underlying brain dysfunction in familial and sporadic schizophrenia
65 at all 3 biochemical disturbances underlying brain dysfunction in phenylketonuria can be targeted by
67 abuse and abstinence may underlie persistent brain dysfunction in primates and be a target for therap
69 increasingly popular technique for studying brain dysfunction in psychiatric patients, and is widely
70 data are compatible with the hypothesis that brain dysfunction in RTT is caused by a loss of the MeCP
72 a need to generate serum measures that index brain dysfunction in the preanemic stage of ID, assess t
75 brain barrier/neurological injury, and acute brain dysfunction, including delirium, remain unexamined
77 cal entity, the pathophysiology resulting in brain dysfunction is not fully understood, although it i
82 prenatally and is Altman's model of "minimal brain dysfunction", may be a factor in at least some for
83 lycemia as a putative contributor to several brain dysfunctions observed in diabetes patients, such a
84 rst-episode schizophrenia indicates that the brain dysfunction occurred before clinical presentation.
85 ficantly more neuropsychological evidence of brain dysfunction on the Halstead Impairment Index (P=.0
86 ociation between lowest daily hemoglobin and brain dysfunction (p = 0.69 for delirium), renal dysfunc
87 understanding these disorders indicate that brain dysfunction precedes neurodegeneration, but the ro
90 movement disorders, the mechanisms by which brain dysfunction results in dystonia are not understood
91 on, it is argued that evidence of underlying brain dysfunction revealed by these pictures often rests
92 nt records from 5 impairment groups (stroke, brain dysfunction, spinal cord dysfunction, other neurol
93 development and infancy could contribute to brain dysfunction such as that seen in ASD and other dev
94 s, including learning and memory, as well as brain dysfunctions such as drug addiction and psychologi
95 mprinting in a number of syndromes involving brain dysfunction, such as Prader-Willi syndrome, Angelm
96 ing on the site of the lesion, the resultant brain dysfunction, the presentation of depression and ti
97 ese results underline the potential of focal brain dysfunction to produce behavioral improvement and
98 t cerebrovascular effects that contribute to brain dysfunction underlying dementia by limiting the de
100 europathology, and character and severity of brain dysfunction varied substantially among cases.
102 ase classification system and the underlying brain dysfunctions, we applied a fully data-driven appro
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。